Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn
  • Landscape

Ricky Solorzano

  • Japan Moves Toward First Commercial iPS Cell Therapies
    March 6, 2026

    Japan Moves Toward First Commercial iPS Cell Therapies

    Ricky Solorzano
  • Cellares Raises $257M to Industrialize Cell Therapy Manufacturing
    March 3, 2026

    Cellares Raises $257M to Industrialize Cell Therapy Manufacturing

    Ricky Solorzano
  • UT Southwestern VITAL Program Wins ARPA-H Award to Bioprint Personalized, Immune-Compatible Livers
    February 26, 2026

    UT Southwestern VITAL Program Wins ARPA-H Award to Bioprint Personalized, Immune-Compatible Livers

    Ricky Solorzano
  • United Therapeutics Reports Breakthrough Phase 1 Results for Bioengineered Liver Support System
    February 20, 2026

    United Therapeutics Reports Breakthrough Phase 1 Results for Bioengineered Liver Support System

    Ricky Solorzano
  • Aspect Biosystems and Novo Nordisk Deepen Partnership to Advance Curative Diabetes Therapies
    February 16, 2026

    Aspect Biosystems and Novo Nordisk Deepen Partnership to Advance Curative Diabetes Therapies

    Ricky Solorzano
  • WFIRM Secures ARPA-H Award to Advance On-Demand Bioprinted Kidneys
    February 13, 2026

    WFIRM Secures ARPA-H Award to Advance On-Demand Bioprinted Kidneys

    Ricky Solorzano
  • Wyss Institute-Led Team Wins ARPA-H PRINT Award to Engineer Universal, Transplant-Ready Liver Grafts known as ImPLANT
    February 12, 2026

    Wyss Institute-Led Team Wins ARPA-H PRINT Award to Engineer Universal, Transplant-Ready Liver Grafts known as ImPLANT

    Ricky Solorzano
  • Carnegie Mellon Team Wins $28.5M ARPA-H Award to Bioprint Regenerative Human Livers
    February 9, 2026

    Carnegie Mellon Team Wins $28.5M ARPA-H Award to Bioprint Regenerative Human Livers

    Ricky Solorzano
  • ARPA-H’s $176M Bet on Bioprinted Organs: Inside the PRINT Program’s Push to End Transplant Shortages
    February 5, 2026

    ARPA-H’s $176M Bet on Bioprinted Organs: Inside the PRINT Program’s Push to End Transplant Shortages

    Ricky Solorzano
  • The Business of Biofabrication: What 2025 Taught Us
    January 3, 2026

    The Business of Biofabrication: What 2025 Taught Us

    Ricky Solorzano
Previous Page
1 2 3 4 5 6 … 16
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    The Business of Biofabrication

    Have a WordPress.com account? Log in now.

  • The Business of Biofabrication
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar